Product Description
Overall, the global minimally invasive fat reduction device market was valued at $651.3 million in 2022. This is expected to increase over the forecast period at a CAGR of 4.7% to reach $897.1 million.
The full report suite on the global minimally invasive fat reduction device market includes cryolipolysis device, ultrasound lipolysis device, laser lipolysis device as well as Kybella® injection segments. Procedure data is further segmented into Kybella®Injection and non-injectable fat reduction procedures.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL MINIMALLY INVASIVE FAT REDUCTION DEVICE MARKET INSIGHTS
Minimally and non-invasive fat reduction approaches have been gaining popularity, fueled by research and development activities, as well as continuing adoption of related technology. With a growing concern regarding weight management, combined with social media promotion of idealized body image, the demand for a safe and effective fat removal approach will sustain the growth in the fat reduction procedure volume, driving sales in the adjustment device market.
GLOBAL MINIMALLY INVASIVE FAT REDUCTION DEVICE MARKET SHARE INSIGHTS
The global minimally invasive fat reduction device market was dominated by Allergan, Merz Aesthetics, and Cynosure.
Allergan, an AbbVie company, led the global minimally invasive fat reduction device market in 2022. As of 2022, Allergan’s CoolSculpting® machine is the only FDA-approved cryolipolysis machine, resulting in the company’s dominant share in the cryolipolysis device market. Kybella® (deoxycholic acid), also known as Belkyra® in Europe, also belongs to Allergan, securing the company’s share in this segment as well.
MARKET SEGMENTATION SUMMARY
- Cryolipolysis Device Market
- Ultrasound Lipolysis Device Market
- Laser Lipolysis Device Market
- Kybella® Injection Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast Period | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Data | Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices |
| Qualitative Data | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.
Read more about iData’s 9-Step Research Methodology |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavor never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
